Akebia Ther (AKBA)

NASDAQ
3.45
+0.12(+3.60%)
Pre Market
3.48
+0.03(+0.87%)
- Real-time Data
  • Volume:
    3,500,189
  • Bid/Ask:
    3.47/3.49
  • Day's Range:
    3.31 - 3.47

AKBA Overview

Prev. Close
3.45
Day's Range
3.31 - 3.47
Revenue
295.31M
Open
3.32
52 wk Range
2.09 - 13.71
EPS
-2.77
Volume
3,500,189
Market Cap
552.4M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
4,633,457
P/E Ratio
-
Beta
1.74
1-Year Change
-72.22%
Shares Outstanding
160,115,163
Next Earnings Date
Aug 11, 2021
What is your sentiment on Akebia Ther?
or
Market is currently closed. Voting is open during market hours.

Akebia Ther News

Akebia Ther Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell

Akebia Ther Company Profile

Akebia Ther Company Profile

Employees
380

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in developing vadadustat as an oral therapy. The Company's vadadustat is a HIF-prolyl-hydroxylase (HIF-PH) inhibitor in Phase III development for the treatment of anemia of CKD. In addition to vadadustat, the Company is engaged in developing a HIF-based portfolio of product candidates that target serious diseases of unmet need. Its portfolio includes product candidates developed internally, such as AKB-6899, as well as in-licensed product candidates, including AKB-5169. AKB-5169 is a preclinical compound in development as an oral treatment for inflammatory bowel disease (IBD).

Read More
  • should I buy the dip ? is it worth it ?
    0
    • Do you like bets? I bought the dip, but it's going deeper...
      1
    • I bought the dip a while back and then it diped even lower and now Im not sure to get the dip again lol
      0
    • meanwhile, some good news...
      0
  • Guys, any ideas where it’s heading?
    0
    • But when NDA news will arrive next month this maybe will be a dollar stock... Any idea why is dropping every day???
      1
      • They have 2 NDA fillings due by mid 2nd Q, so around May
        1
        • Sooon it will go up
          0
          • When 😛😛😛😛😛🤭🤭🤭
            0
        • Seems good news are on the way, just need to check Fibrogen, downgraded quite badly
          1
          • 1º Institutions loading up, 2º They Hired many ppl , sales team included, 3º They hired Mrs Zumwalt who was Vice president & Government Affairs at DaVita. Why he joined AKBA if they didn´t have a good chance to be a major player. it could literally ruin his entire carrer 4º $FGEN one os his biggest competitors has a "inconclusive " data results & enormous market cap compare to his sales. 5º Vadadustad already aprroved in Japan 6º Distribution Agreement signed which is huge advantage. 7º They are trying to get in European & chinease markets
            0
            • entry for 3.30 n below
              2
              • Akebia Therapeutics Appoints LeAnne M. Zumwalt, Dialysis Industry Leader, to Board of Directors
                0
                • https://finance.yahoo.com/news/akebia-therapeutics-appoints-leanne-m-130000588.html
                  0
                  • http://www.conferencecalltranscripts.org/summary/?id=8923411
                    0
                    • target price long term : 6.50 - 8.00mid term : 4.85 - 5.85cut loss : 3.75
                      0
                      • Are you sure it isn´t heading to 9-12 ??
                        0
                      • from the charts.. mid term goals target for above 4.85 range has reach and making towards 5.85...heading towards 9 to 12 maybe 50/50 chance..we wait for the second target that is 6.50 n above..else should find CL n go to other counter ..
                        0
                      • from the charts.. mid term goals target for above 4.85 range has reach and making towards 5.85...heading towards 9 to 12 maybe 50/50 chance..we wait for the second target that is 6.50 n above..else should find CL n go to other counter ..
                        0
                    • 4.09
                      0
                      • Have a look this link guys : https://www.clinicaltrials.gov/ct2/show/NCT04478071?term=vadadustat&draw=2&rank=10
                        1
                        • to the moon!
                          0
                          • It will be parabolic if they get approved by FDA. It is a really good investment
                            0
                            • Now whats the concensus?
                              0
                              • is it getting approved?
                                1
                                • skyrocket like cassava... just patient...
                                  3
                                  • read my comment 10 days ago. keep disliking me ^_^
                                    2
                                    • Hedeby Aeppeltyskenso...where is the 4 you bull about?
                                      0
                                    • Tony Lowit was 2.5 to 3.5 its almost 4 :P
                                      0
                                    • here^_^ i am rich and u a bi..
                                      0
                                  • price target now is 15$!
                                    1
                                    • my friend we will wait for this together !
                                      0
                                    • Not now
                                      0
                                  • No buys from the insiders even for souch dump price
                                    0
                                    • yes thats why you need to buy
                                      2
                                  • buy now or cry later
                                    7
                                    • 2 weeks this will be 4
                                      3
                                      • well because it already was 4
                                        3
                                      • why 2 weeks?
                                        0
                                      • 1. New Akba is not a Bubble2. Akba was 12 year ago 3. Akba is on the lowest price4. Akba is Pharmacy. Kidney disease. 5.Hom many companies researching same drugs? 0 or i dont know
                                        6
                                    • :)
                                      2
                                      • Hedeby said truth) i already put my money in AKBA! go go go AkBa!
                                        2
                                      • Hedeby said truth) i already put my money in AKBA! go go go AkBa!
                                        1
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.